Navigation Links
World's First Cattle Vaccine to Reduce E. coli O157 Threat Receives Full Licensing Approval in Canada
Date:10/27/2008

r that humans are exposed to, and thus, dropping the disease levels in humans."

On-farm interventions to reduce the shedding of E. coli O157:H7 by cattle, such as simple vaccination of cattle with Econiche, have the potential to reduce food and water contamination and the consequences associated with human infection with the deadly bacteria. Clinical trials conducted with Econiche have shown a significant reduction in the amount of E. coli shed in the manure of vaccinated cows.

"We've been trying to do our part to be an industry leader in food safety," said Kym Anthony, owner of specialty beef producer Top Meadow Farms in Clarksburg, Ontario, who has been using the vaccine for the past year under Permit to Distribute Veterinary Biologics. "The E. coli vaccine fits into that. It's been a missing link in the industry thus far."

Human exposure and infection with E. coli O157:H7 can result in serious health consequences, including abdominal pain and severe bloody diarrhea. In severe cases, kidney damage can occur and progress to serious complications and even death.

"The announcement of this vaccine's full Canadian licence is great news," said Dr. Hazel Lynn, Medical Officer of Health for the Grey Bruce Health Unit, which includes the town of Walkerton, Ontario, where seven people died and more than 2,000 became ill in May 2000 as a result of contamination of the town's water supply with E. coli O157:H7 in cattle manure from a local farm. "This is an innovative way to reduce this public health risk."

Another important risk area for the public to be infected by the bacteria is through contact with farm animals at petting zoos and agricultural exhibitions. Vaccinating these animals with Econiche can help greatly reduce this risk of bacteria transmission, something that has been recognized by the Canadian Association of Fairs and Exhibitions (C.A.F.E.).

"C.A.F.E. supports any intervention that will reduce the amount of E. coli O157
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. BODY WORLDS 2 & Breathe California Pair Up for Some Ash Kicking
2. BODY WORLDS 3 & The Story of the Heart Opens at the California Science Center, March 14, 2008
3. Museum Open Around the Clock - BODY WORLDS 2 and The Tech Host 40 Hour Marathon!
4. The Institute for Plastination Responds to the Bishop of Manchesters Media Blitz, Assertions, and Allegations About BODY WORLDS Anatomical Exhibition Coming to Manchester
5. Specimens in BODY WORLDS Exhibitions Stem Primarily from German Body Donation Program
6. California Science Center Welcomes 1-Millionth BODY WORLDS Visitor
7. Gunther Von Hagens BODY WORLDS Exhibitions Mark 25th Million Visitor Milestone
8. Gunther von Hagens BODY WORLDS Exhibitions Welcome Specimens From Worlds First Living Body Donor for Plastination
9. First biomarker discovered that predicts prostate cancer outcome
10. FDA Approves First Anti-Psychotic for Kids
11. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... The Sports Conflict Institute is pleased to announce ... of conflict resolution professionals. Baroff comes to SCI as an ... over 30 years experience as an arbitrator, educator, and ombuds ... connect with SCI and bring my conflict resolution skills and ... a complete sports focus,” says Baroff. , “Roy has a ...
(Date:11/22/2014)... JOSE, Calif. (PRWEB) November 22, 2014 ... security applications was announced today which safely detects ... using high frequency radio waves. Developed by RHT ... images and hosts broad applications in other areas ... addition to security. , Using high frequency radio ...
(Date:11/22/2014)... “Greenfield Naturals” was featured on NewsWatch as part ... the latest and coolest technology products available to consumers. ... conducted the product review and shared with viewers how ... , From pollution to hazardous substances in water, harmful ... to remove these chemicals, especially in water. , A ...
(Date:11/22/2014)... A Xarelto lawsuit has been filed on behalf ... million in damages from the makers and marketers of the ... the woman began using Xarelto in March 2012 and used ... she suffered life-threatening bleeding in July 2012 and as a ... emotional distress. The lawsuit purports that the woman’s injuries are ...
(Date:11/22/2014)... Many young people consider hookahs a hip and safer ... from the water pipes contain the toxin benzene. ... leukemia in prior research, according to a scientific team ... Biomarkers & Prevention . "In contrast to what ... alternative to smoking other forms of tobacco," study author ...
Breaking Medicine News(10 mins):Health News:SCI Announces New Team Member Roy Baroff 2Health News:SCI Announces New Team Member Roy Baroff 3Health News:RHT SpectraSafe announces a Radical New Airport Security Technology that Is More Effective, Less Invasive 2Health News:An Easy Home Solution to Get Better Tasting Water was Featured on NewsWatch Television on October 30, 2014 2Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 2Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 3Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 4Health News:Hookahs Deliver Toxic Benzene in Every Puff, Study Shows 2
... 22, 2009 High cholesterol levels are considered to ... including stroke, but also for the development of Alzheimer,s ... been developed in recent years. In addition to the ... the University of Groningen, The Netherlands, and her co-investigators ...
... WELLESLEY HILLS, Mass., June 22 Joseph F. Finn, ... has focused on developing GCS-100 for treatment of three ... and diffuse large B cell lymphoma ("DLBCL"). In ... agent in CLL and in combination with existing therapy ...
... Governor & First Lady,s Medals for Service, Join CaliforniaVolunteers ... and Participate in Conference,s Opening General Session , ... Maria Shriver will continue her dedication to encouraging all ... first annual Governor and First Lady,s Medals for Service, ...
... With changes in the nation,s healthcare system looming and overall ... for debut at the Wynn Las Vegas this November has ... into alternative careers. The Medical Fusion conference ( ... that is tapping into the growing frustration of physicians practicing ...
... patient education programs. , , NEW YORK, ... industry, building relationships directly with patients is a ... research tool allows pharmaceutical marketers to identify all ... to prioritize and optimize those interactions. The ...
... animals and humans, study finds , MONDAY, June ... aureus (MRSA) infections between pets and humans are ... the skin, soft-tissue and surgical infections, say researchers ... "Pet owners are often unaware of the potential ...
Cached Medicine News:Health News:Prospect Therapeutics Inc.'s GCS-100 Has Focused on Developing Treatment for Three Blood-Borne Cancers 2Health News:First Lady Michelle Obama and California First Lady Maria Shriver Kick Off 2009 National Conference on Volunteering & Service with Playground Service Project 2Health News:First Lady Michelle Obama and California First Lady Maria Shriver Kick Off 2009 National Conference on Volunteering & Service with Playground Service Project 3Health News:First Lady Michelle Obama and California First Lady Maria Shriver Kick Off 2009 National Conference on Volunteering & Service with Playground Service Project 4Health News:First Lady Michelle Obama and California First Lady Maria Shriver Kick Off 2009 National Conference on Volunteering & Service with Playground Service Project 5Health News:Physician Dissatisfaction Leads to New Medical Conference 2Health News:Physician Dissatisfaction Leads to New Medical Conference 3Health News:Data Development Worldwide Helps Pharmaceutical Marketers Optimize Relationship Marketing to Patients 2Health News:A Pet's Bite Can Pass on MRSA 2
(Date:11/21/2014)... Clementia Pharmaceuticals, Inc.  announced ... has granted Orphan Medicinal Product Designation for ... the treatment of fibrodysplasia ossificans progressiva (FOP). ... disease characterized by painful, recurrent episodes of ... bone formation. This process, known as heterotopic ...
(Date:11/21/2014)... 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ) announced ... will be presenting at the 26 th Annual Piper ... New York . The formal presentation is ... In addition, Mr. Krakauer and Jorgen B. Hansen , ... during the day. An audio webcast will ...
(Date:11/21/2014)... November 2014 Michael DeMarco (42) ... des 14. Februar 2014 zugetragen hat. Seine Tochter Aly ... Video - http://youtu.be/5cVoMCe0uiE ... mein morgendliches Training zu machen", erzählt Michael DeMarco ... Zeit begeisterte Anhänger der CrossFit-Trainingsmethode. Ich war auf ...
Breaking Medicine Technology:Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3
... 17, 2012  Eisai announced today that 15 abstracts highlighting new ... Annual Meeting of the American Society of Clinical Oncology (ASCO), ... 2012. These studies highlight Eisai,s current product ... and their families affected by cancer. "Our ...
... Janssen Pharmaceuticals, Inc. today announced the results ... ER (tapentadol) extended-release tablets were significantly more effective ... with chronic moderate to severe, painful diabetic peripheral ... at the 31st Annual Scientific Meeting of the ...
Cached Medicine Technology:Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting 2Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting 3Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting 4Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting 5Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting 6Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting 7Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting 8Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting 9Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 2Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 3Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 4Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 5Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 6Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 7Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 8Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 9Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 10Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 11Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 12
... has been manufacturing the Anne Klein brand ... eyewear collections are designed for an all-female ... Anne Klein eyewear identifies herself with the ... career woman who is image-conscious and quality-conscious ...
... eyewear designs with children in mind, making ... and stay-put cable temples. Its not surprising ... Research as the best selling childrens collection ... so popular is its ability to keep ...
... frame mounting technology has redefined rimless collections ... taper at the end of each frame ... of the bushing that mounts within the ... a secure fit is created that far ...
... In 1993, Kate Spade entered the accessories world ... fabric. Since then, she has taken her simple ... accessory brand. Clean, modern shapes, a nod to ... element of surprise are the fundamental principles of ...
Medicine Products: